Search research articles
Contact Us
Filters
Showing results (11-20 of 43) with videos related to
Page
of 5
Sort By:
BMC Cancer
|
April 22, 2022
Underdiagnosis of iron deficiency anemia among patients with colorectal cancer: an examination of electronic medical records
Trishnee Bhurosy, Anika Jishan, Patrick M Boland, et al.
ACG Case Reports Journal
|
June 18, 2020
Use of Fecal Microbial Transplantation for Immune Checkpoint Inhibitor Colitis
Micaela K Fasanello, Kevin T Robillard, Patrick M Boland, et al.
Journal of Gastrointestinal Oncology
|
January 24, 2022
Ovarian transposition and metachronous ovarian metastasis in a premenopausal colorectal carcinoma patient: a case report
Shari Bodofsky, Sean Hong, George N Botros, et al.
Clinical Colorectal Cancer
|
April 20, 2017
Adjuvant Chemotherapy Is Associated With Improved Overall Survival in Locally Advanced Rectal Cancer After Achievement of a Pathologic Complete Response to Chemoradiation
Danish Shahab, Emmanuel Gabriel, Kristopher Attwood, et al.
Oncotarget
|
April 29, 2020
A phase II study of axalimogene filolisbac for patients with previously treated, unresectable, persistent/recurrent loco-regional or metastatic anal cancer
Cathy Eng, Marwan Fakih, Manik Amin, et al.
Targeted Oncology
|
December 6, 2019
Phase I Study of Irinotecan/5-Fluorouracil/Leucovorin (FOLFIRI) with Sunitinib for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
Sarbajit Mukherjee, Christos Fountzilas, Patrick M Boland, et al.
Surgical Oncology
|
March 11, 2019
Nonoperative management after neoadjuvant therapy for rectal cancer: A single institution experience over 5 years
Matthew Strode, Rupen Shah, Patrick M Boland, et al.
Clinical and Translational Medicine
|
May 23, 2022
FL118, acting as a 'molecular glue degrader', binds to dephosphorylates and degrades the oncoprotein DDX5 (p68) to control c-Myc, survivin and mutant Kras against colorectal and pancreatic cancer with high efficacy
Xiang Ling, Wenjie Wu, Ieman A M Aljahdali, et al.
American Journal of Cancer Research
|
March 25, 2017
Topoisomerase I (Top1): a major target of FL118 for its antitumor efficacy or mainly involved in its side effects of hematopoietic toxicity?
Fengzhi Li, Xiang Ling, Danni L Harris, et al.
Oncotarget
|
October 27, 2015
Comprehensive multiplatform biomarker analysis of 199 anal squamous cell carcinomas
Brandon G Smaglo, Anteneh Tesfaye, Thorvardur R Halfdanarson, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 43) with videos related to
Sort By:
Page
of 5
BMC Cancer
|
April 22, 2022
Underdiagnosis of iron deficiency anemia among patients with colorectal cancer: an examination of electronic medical records
Trishnee Bhurosy, Anika Jishan, Patrick M Boland, et al.
ACG Case Reports Journal
|
June 18, 2020
Use of Fecal Microbial Transplantation for Immune Checkpoint Inhibitor Colitis
Micaela K Fasanello, Kevin T Robillard, Patrick M Boland, et al.
Journal of Gastrointestinal Oncology
|
January 24, 2022
Ovarian transposition and metachronous ovarian metastasis in a premenopausal colorectal carcinoma patient: a case report
Shari Bodofsky, Sean Hong, George N Botros, et al.
Clinical Colorectal Cancer
|
April 20, 2017
Adjuvant Chemotherapy Is Associated With Improved Overall Survival in Locally Advanced Rectal Cancer After Achievement of a Pathologic Complete Response to Chemoradiation
Danish Shahab, Emmanuel Gabriel, Kristopher Attwood, et al.
Oncotarget
|
April 29, 2020
A phase II study of axalimogene filolisbac for patients with previously treated, unresectable, persistent/recurrent loco-regional or metastatic anal cancer
Cathy Eng, Marwan Fakih, Manik Amin, et al.
Targeted Oncology
|
December 6, 2019
Phase I Study of Irinotecan/5-Fluorouracil/Leucovorin (FOLFIRI) with Sunitinib for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
Sarbajit Mukherjee, Christos Fountzilas, Patrick M Boland, et al.
Surgical Oncology
|
March 11, 2019
Nonoperative management after neoadjuvant therapy for rectal cancer: A single institution experience over 5 years
Matthew Strode, Rupen Shah, Patrick M Boland, et al.
Clinical and Translational Medicine
|
May 23, 2022
FL118, acting as a 'molecular glue degrader', binds to dephosphorylates and degrades the oncoprotein DDX5 (p68) to control c-Myc, survivin and mutant Kras against colorectal and pancreatic cancer with high efficacy
Xiang Ling, Wenjie Wu, Ieman A M Aljahdali, et al.
American Journal of Cancer Research
|
March 25, 2017
Topoisomerase I (Top1): a major target of FL118 for its antitumor efficacy or mainly involved in its side effects of hematopoietic toxicity?
Fengzhi Li, Xiang Ling, Danni L Harris, et al.
Oncotarget
|
October 27, 2015
Comprehensive multiplatform biomarker analysis of 199 anal squamous cell carcinomas
Brandon G Smaglo, Anteneh Tesfaye, Thorvardur R Halfdanarson, et al.
Page
of 5